Pfizer's Abrysvo vaccine prevents RSV-induced LRTD in infants. It's given as a single-dose injection to pregnant individuals between 32 to 36 weeks of gestation.
Respiratory Syncytial Virus (RSV) is a global pathogen that can cause severe respiratory tract illness. RSV infections can be especially dangerous for newborns and infants in general. A large-scale international vaccination study involving Charité – Universitätsmedizin Berlin and the London School of Hygiene and Tropical Medicine has now investigated the efficacy of an initial vaccine candidate. Participants were given the vaccine during pregnancy. As the researchers describe in The New England Journal of Medicine , up to 81 percent of the participants’ children were reliably protected against severe illness during the first six months of life.
2023-04 - Respiratory virus plagues SA but new vaccine for pregnant moms saves babies wits.ac.za - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wits.ac.za Daily Mail and Mail on Sunday newspapers.